Literature DB >> 36261298

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as Intracranial Hypertension: A Case Report.

Jaydip Ray Chaudhuri1, Jui Jade Bagul2, Alluri Swathi2, Bhim Sen Singhal2, N Chakradhar Reddy2, Kiran Kumar Vallam2.   

Abstract

The production of autoantibodies against myelin oligodendrocyte glycoprotein (MOG) can cause a spectrum of autoimmune disorders, including optic neuritis, transverse myelitis, brainstem encephalitis, and acute disseminated encephalomyelitis. In this study, we present the case of a 19-year-old woman with an unusual clinical presentation of intracranial hypertension (IH) and bilateral papilledema. The patient presented with symptoms of increased intracranial pressure, which followed a relapsing, remitting course over several months. Serial CSF studies showed an increased opening pressure during clinical relapses. The CSF and serum tested positive for MOG immunoglobulin G antibodies. Contrast-enhanced MRI of the brain showed mild meningeal enhancement in the left parietal region with subtle underlying cortical hyperintensities, indicating possible fluid-attenuated inversion recovery variable unilateral enhancement of the leptomeninges. The patient responded well to immunosuppressive therapy using rituximab. The presentation of MOG antibody-associated disease (MOGAD) as IH without optic neuritis is rare. This report presents the first description of a relapsing remitting course presenting each time with only symptoms of raised intracranial pressure, without developing any typical clinical manifestations of MOGAD.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36261298      PMCID: PMC9581460          DOI: 10.1212/NXI.0000000000200020

Source DB:  PubMed          Journal:  Neurol Neuroimmunol Neuroinflamm        ISSN: 2332-7812


  12 in total

Review 1.  MRI features of demyelinating disease associated with anti-MOG antibodies in adults.

Authors:  Marc Denève; Damien Biotti; Sofia Patsoura; Marine Ferrier; Zuzana Meluchova; Laurence Mahieu; Françoise Heran; Catherine Vignal; Romain Deschamps; Olivier Gout; Nicolas Menjot de Champfleur; Xavier Ayrignac; Clarisse Carra Dallière; Pierre Labauge; Cécile Dulau; Thomas Tourdias; Hervé Dumas; Christophe Cognard; David Brassat; Fabrice Bonneville
Journal:  J Neuroradiol       Date:  2019-06-20       Impact factor: 3.447

2.  PRES-like presentation in MOG antibody-related demyelination (MARD).

Authors:  Joel Corbett; Sandeep Bhuta; Kerri Prain; Fabienne Brilot; Arman Sabet; Simon A Broadley
Journal:  J Clin Neurosci       Date:  2020-01-22       Impact factor: 1.961

3.  Glial and neuronal antibodies in patients with idiopathic intracranial hypertension.

Authors:  Güneş Altıokka-Uzun; Ece Erdağ; Betül Baykan; John Tzartos; Duygu Gezen-Ak; Bedia Samancı; Erdinç Dursun; Paraskevi Zisimopoulou; Katerina Karagiorgou; Christos Stergiou; Erdi Şahin; Esme Ekizoğlu; Murat Kürtüncü; Erdem Tüzün
Journal:  Neurol Sci       Date:  2017-07-21       Impact factor: 3.307

4.  'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Yael Hacohen; Thomas Rossor; Kshitij Mankad; Wk 'Kling' Chong; Andrew Lux; Evangeline Wassmer; Ming Lim; Frederik Barkhof; Olga Ciccarelli; Cheryl Hemingway
Journal:  Dev Med Child Neurol       Date:  2017-12-30       Impact factor: 5.449

5.  Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder.

Authors:  Manjunath Netravathi; Vikram Venkappayya Holla; Atchayaram Nalini; Ravi Yadav; Seena Vengalil; Abel Thomas Oommen; Sultana Shaik Reshma; Nitish Kamble; Priya Treesa Thomas; Bhat Maya; Pramod Kumar Pal; Anita Mahadevan
Journal:  J Neurol       Date:  2020-11-13       Impact factor: 4.849

6.  Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Authors:  John J Chen; Eoin P Flanagan; Jiraporn Jitprapaikulsan; Alfonso Sebastian S López-Chiriboga; James P Fryer; Jacqueline A Leavitt; Brian G Weinshenker; Andrew McKeon; Jan-Mendelt Tillema; Vanda A Lennon; W Oliver Tobin; B Mark Keegan; Claudia F Lucchinetti; Orhun H Kantarci; Collin M McClelland; Michael S Lee; Jeffrey L Bennett; Victoria S Pelak; Yanjun Chen; Gregory VanStavern; Ore-Ofe O Adesina; Eric R Eggenberger; Marie D Acierno; Dean M Wingerchuk; Paul W Brazis; Jessica Sagen; Sean J Pittock
Journal:  Am J Ophthalmol       Date:  2018-07-26       Impact factor: 5.258

7.  Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations.

Authors:  Ram N Narayan; Cynthia Wang; Peter Sguigna; Khalil Husari; Benjamin Greenberg
Journal:  Mult Scler Relat Disord       Date:  2018-10-03       Impact factor: 4.339

8.  Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.

Authors:  Sudarshini Ramanathan; Shekeeb Mohammad; Esther Tantsis; Tina Kim Nguyen; Vera Merheb; Victor S C Fung; Owen Bruce White; Simon Broadley; Jeannette Lechner-Scott; Steve Vucic; Andrew P D Henderson; Michael Harry Barnett; Stephen W Reddel; Fabienne Brilot; Russell C Dale
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-11-15       Impact factor: 10.154

9.  Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.

Authors:  Sven Jarius; Hannah Pellkofer; Nadja Siebert; Mirjam Korporal-Kuhnke; Martin W Hümmert; Marius Ringelstein; Paulus S Rommer; Ilya Ayzenberg; Klemens Ruprecht; Luisa Klotz; Nasrin Asgari; Tobias Zrzavy; Romana Höftberger; Rafik Tobia; Mathias Buttmann; Kai Fechner; Kathrin Schanda; Martin Weber; Susanna Asseyer; Jürgen Haas; Christian Lechner; Ingo Kleiter; Orhan Aktas; Corinna Trebst; Kevin Rostasy; Markus Reindl; Tania Kümpfel; Friedemann Paul; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2020-09-03       Impact factor: 8.322

10.  A multicenter comparison of MOG-IgG cell-based assays.

Authors:  Patrick J Waters; Lars Komorowski; Mark Woodhall; Sabine Lederer; Masoud Majed; Jim Fryer; John Mills; Eoin P Flanagan; Sarosh R Irani; Amy C Kunchok; Andrew McKeon; Sean J Pittock
Journal:  Neurology       Date:  2019-02-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.